Phase II study of HP-5070

A double-blind comparative study of HP-5070 in patients with primary hyperhidrosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224089

Enrollment

180

Registered

2018-10-11

Start date

2018-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary local hyperhidrosis

Interventions

investigational material(s) Generic name etc : HP-5070 INN of investigational material : Therapeutic category code : 129 Other agents affecting peripheral nervous system Dosage and Administration for

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients with a diagnosis of primary local hyperhidrosis

Exclusion criteria

Exclusion criteria: - Patients with secondary hyperhidrosis - Patients with heavy sweating due to climacteric disturbance - Patients who have undergone surgery for hyperhidrosis (sympathectomy, nerve block, laser surgery, etc.)

Design outcomes

Primary

Measure	Time frame
Efficacy	—

Secondary

Measure	Time frame
Safety, and pharmacokinetics	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026